Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease

NCT04326465 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04326465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04326465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2021
Completion date
December 31, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peyronies disease